There was indeed a positive correlation between HOXB2 and both ESR1 and PGR, allowing the conclusion to be drawn that low expression of HOXB2 could lead to the transition of ER+ and/or PR+ breast cancers to express less hormone receptors, and display more aggressive phenotypes like TNBC. This evidence concerns the gene HOXB2 and breast cancer.